Elsevier MDL releases MDL® Logistics 1.0

Effectively manages chemical reagent procurement and inventory tracking needs of research centers

SAN LEANDRO, CA − September 28, 2005 − Elsevier MDL has introduced MDL® Logistics, a new reagent procurement and inventory management application developed in collaboration with customers to meet the needs of research organizations. MDL Logistics simplifies the process of locating, purchasing and tracking essential chemical materials and is the only effective solution on the market offering regulatory capabilities such as managing, tracking, and reporting on controlled substances in an organization.

"Researchers now have a comprehensive system that offers cradle-to-grave procurement and inventory management," said Dr. Trevor Heritage, Senior Vice President, Elsevier MDL Workflow Business Group. "MDL Logistics boosts researcher productivity, delivers cost savings through optimized reagent management and, importantly, allows researchers to focus on scientific tasks."

With MDL Logistics, all the tools to manage inventory are at a researcher's fingertips. MDL Logistics provides access to the MDL® Available Chemicals Directory database (the industry-standard collection of chemical supplier catalogs) as well as to the in-house inventory. It integrates with leading commercial purchasing systems and laboratory hardware devices (barcode printers, scanners, balances, inventory robotics), and offers support for multiple workflows at different sites.

Built on new-generation MDL® Isentris technology (the open-standard, tiered informatics platform for life sciences), MDL Logistics also allows organizations on a customization basis to add new data sources, including real-time supplier data. For more information, visit www.mdl.com or contact an Elsevier MDL Account Manager to arrange a demonstration.

About Elsevier MDL
Elsevier MDL provides informatics, database and workflow solutions that accelerate successful life sciences R&D by improving the speed and quality of scientists' decision making. Researchers around the world depend on Elsevier MDL for innovative and reliable discovery informatics software solutions and services augmented by 400 Elsevier chemistry and life sciences journals and related products. For more information, visit www.mdl.com. Elsevier is a world-leading publisher of scientific, technical and medical information products and services. For more information visit www.elsevier.com. Elsevier is part of Reed Elsevier Group plc, a world-leading publisher and information provider. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

About Elsevier
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com

Media Contacts:
Dr. Phil McHale
Elsevier MDL
VP, Market & Corporate Communications
Phone: (510) 357-2222 ext. 3541


MDL and Isentris are registered trademarks of MDL Information Systems, Inc. ('Elsevier MDL') in the United States. All rights reserved.